Informed-money record
ONCY · ONCOLYTICS BIOTECH INC
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
14
Bearish filings
1
Named actors
10
Disclosed $ (bull / bear)
$363K / $0
Recent disclosures
15 of 15 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-04-06 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-03-12 | Chief Executive Officer Kelly Jared | bought | $5K | SEC ↗ |
| 2026-03-11 | Director Parsons James T. | bought | $10K | SEC ↗ |
| 2026-02-12 | Director Andrews Patricia S | bought | $30K | SEC ↗ |
| 2026-02-12 | Director Brown Deborah Margaret | bought | $21K | SEC ↗ |
| 2026-02-12 | VP, Product Development Hagerman Allison | bought | $8K | SEC ↗ |
| 2026-02-12 | Chief Medical Officer Heineman Thomas Charles | bought | $10K | SEC ↗ |
| 2026-02-12 | Chief Executive Officer Kelly Jared | bought | $25K | SEC ↗ |
| 2026-02-12 | Chief Financial Officer Look Kirk | bought | $10K | SEC ↗ |
| 2026-02-12 | Director Pisano Wayne | bought | $25K | SEC ↗ |
| 2026-02-12 | Director Seizinger Bernd R. | bought | $34K | SEC ↗ |
| 2026-02-11 | Chief Business Officer Aromando Andrew | bought | $25K | SEC ↗ |
| 2026-02-11 | Chief Executive Officer Kelly Jared | bought | $5K | SEC ↗ |
| 2026-02-11 | Director Seizinger Bernd R. | bought | $50K | SEC ↗ |
| 2026-01-16 | Director Seizinger Bernd R. | bought | $104K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals